Atossa Therapeutics Joins ARDD 2026 Clinical Trials Panel
Seattle, Washington, U.S., September 24, 2026 Atossa Therapeutics Inc. announced that its Chief Executive Officer and Founder, Dr. Steven...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Seattle, Washington, U.S., September 24, 2026 Atossa Therapeutics Inc. announced that its Chief Executive Officer and Founder, Dr. Steven...
Minneapolis, Minnesota, U.S., September 24, 2026 Marani Health has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Stockholm, Sweden, August 19, 2026 BioArctic AB and Mesenkia Therapeutics have entered a research collaboration to explore a novel...
Ramat Gan, Israel, August 19, 2026 Pulsenmore Ltd. announced the expansion of its home ultrasound activities in Israel following...
Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...
Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...
Waltham, Mass., August 10, 2026 Revvity, Inc. announced the launch of its SuperFlexâ„¢ prenatal screening system, a compact, CE-IVDR...
LAWRENCEVILLE, N.J., July 21, 2026 IMUNON, Inc. has announced positive preliminary Phase 2 minimal residual disease (MRD) clinical data...
SALT LAKE CITY, Utah, July 21, 2026 Myriad Genetics has officially launched the FirstGene® Multiple Prenatal Screen, introducing what...
SOUTH SAN FRANCISCO, Calif. | July 9, 2026 Denali Therapeutics has announced that co-founder and Chief Executive Officer Ryan...
